文献速递胃肠外科围术期管理与 ERAS

微创与开放结肠切除术长期阿片类药物使用的全国数据库倾向评分匹配比较

A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use.
PubMed 文献 · Surg Endosc · 2021-02-10

基于MarketScan数据库2013-2017年因良恶性疾病行结肠切除的既往未使用阿片类患者,倾向评分匹配后比较微创与开放手术。微创手术显著降低长期阿片类药物使用(任何阿片类13.3% vs 20.9%),机器人辅助较腹腔镜减少高剂量阿片类使用(2.1% vs 3.8%)。

要点

  • 微创结肠切除较开放手术显著降低长期任何阿片类、II/III类及高剂量阿片类处方率。
  • 机器人辅助结肠切除较腹腔镜降低长期高剂量阿片类处方率。
  • 年轻、良性指征、吸烟、精神疾病及>6种Charlson合并症是长期阿片类使用的危险因素。

核心结论

  • 微创结肠切除较开放手术显著降低长期阿片类药物使用。
  • 机器人辅助结肠切除较腹腔镜降低长期高剂量阿片类使用。
  • 增加微创结肠切除(包括适当使用机器人辅助)可能减少长期阿片类使用。

研究设计与样本

  • 回顾性分析MarketScan数据库2013-2017年因良恶性疾病行结肠切除的患者。
  • 纳入既往未使用阿片类且围术期(术前30天至出院后14天)至少配药1次的患者。
  • 采用倾向评分匹配比较开放与微创、腹腔镜与机器人辅助手术。
  • 微创与开放匹配5413对,机器人辅助与腹腔镜匹配1195对。

主要发现

  • 微创较开放手术长期任何阿片类处方率13.3% vs 20.9%(p<0.001)。
  • 微创较开放手术长期II/III类阿片类处方率11.7% vs 19.2%(p<0.001)。
  • 微创较开放手术长期高剂量阿片类处方率4.3% vs 7.7%(p<0.001)。
  • 机器人辅助较腹腔镜长期高剂量阿片类处方率2.1% vs 3.8%(p=0.015)。
  • 长期阿片类使用危险因素包括年轻、良性指征、吸烟、精神疾病及>6种Charlson合并症。

关键数值与推荐

  • 长期阿片类使用定义为出院后90-180天至少配药1次长期阿片类处方。
  • 围术期阿片类处方定义为术前30天至出院后14天至少配药1次。

临床怎么用

  • 对适合患者优先选择微创结肠切除以降低长期阿片类使用风险。
  • 适当情况下可选择机器人辅助结肠切除以减少高剂量阿片类使用。
  • 对年轻、良性指征、吸烟、精神疾病及多合并症患者加强阿片类管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid dependence is a public health crisis and surgery is a risk factor for long-term opioid use. Though minimally invasive surgery (MIS) is associated with less perioperative pain, demonstrating an association with less long-term opioid use would be another reason to justify adoption of minimally invasive techniques. We compared the rates for long-term opioid prescriptions among patients in a large national database who underwent minimally invasive and open colectomy. METHODS: Using the MarketScan Database, we retrospectively analyzed patients undergoing colon resection for benign and malignant diseases between 2013 and 2017. Among opioid-naïve patients who had ≥ 1 opioid prescriptions filled perioperatively (30 days before surgery to 14 days after discharge), propensity score matching was applied for group comparisons [open (OS) versus MIS, and laparoscopic (LS) versus robotic-assisted surgery (RS)]. The primary outcome was long-term opioid use defined as the proportion of patients with ≥ 1 long-term opioid prescriptions filled 90-180 days after discharge. Risks factors for long-term opioid use were assessed using logistic regression. RESULTS: Among the 5413 matched pairs in the MIS versus OS cohorts, MIS significantly reduced long-term opioid use of 'any opioids' (13.3% vs. 20.9%), schedule II/III opioids (11.7% vs. 19.2%), and high-dose opioids (4.3% vs. 7.7%; all p < 0.001). Among the 1195 matched pairs in the RS versus LS cohorts, RS was associated with less high-dose opioids (2.1% vs. 3.8%, p = 0.015) 90-180 days after discharge. Other risk factors for long-term opioid use included younger age, benign indications, tobacco use, mental health conditions, and > 6 Charlson comorbidities. CONCLUSION: Minimally invasive colectomy is associated with a significant reduction in long-term opioid use when compared to OS. Robotic-assisted colectomy was associated with less high-dose opioids compared to LS. Increasing adoption of minimally invasive surgery for colectomy and including RS, where appropriate, may decrease long-term opioid use.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Bastawrous AL, Brockhaus KK, Chang MI, et al. A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use. Surg Endosc. 2021. PMID: 33569727. doi:10.1007/s00464-021-08338-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。